HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antidiabetic effects and underlying mechanisms of anti-digestive dietary polysaccharides from Sargassum fusiforme in rats.

Abstract
Sargassum fusiforme polysaccharides (SFP), an anti-digestive biologically active ingredient obtained from Sargassum fusiforme by ultrasound-assisted enzymatic extraction, have been proven to exhibit extremely strong alpha-glucosidase inhibitory activity. In the current research, the potential anti-diabetic effects and molecular mechanisms of SFP were investigated by classic biochemical analysis, high-throughput sequencing and molecular biology techniques in type 2 diabetic rats. The analysis of typical diabetic symptoms and serum profiles showed that oral administration of SFP could mitigate hyperglycemia, hyperinsulinemia, dyslipidemia and oxidative stress in diabetic rats. SFP also promoted glycogen synthesis in the liver and skeletal muscles. H&E staining observation confirmed that SFP intervention could partially repair liver and muscle injuries caused by diabetes. Moreover, 16S rRNA gene sequencing analysis indicated that SFP treatment could distinctly restore the beneficial composition of gut flora in diabetic rats. Furthermore, RT-qPCR analysis revealed that anti-diabetic effects of SFP may be closely related to accelerating the absorption and utilization of blood glucose in the liver and muscle and inhibiting hepatic glucose production. In short, this study demonstrated that SFP could be developed as functional foods or pharmaceutical supplements for the prevention or mitigation of diabetes and its complications.
AuthorsRui-Bo Jia , Zhao-Rong Li , Juan Wu , Zhi-Rong Ou , Baoguo Sun , Lianzhu Lin , Mouming Zhao
JournalFood & function (Food Funct) Vol. 11 Issue 8 Pg. 7023-7036 (Aug 01 2020) ISSN: 2042-650X [Electronic] England
PMID32716443 (Publication Type: Journal Article)
Chemical References
  • Blood Glucose
  • Dietary Carbohydrates
  • Hypoglycemic Agents
  • Polysaccharides
  • RNA, Ribosomal, 16S
Topics
  • Animals
  • Blood Glucose (drug effects)
  • Diabetes Mellitus, Experimental
  • Diabetes Mellitus, Type 2 (blood, therapy)
  • Dietary Carbohydrates (pharmacology)
  • Digestion (drug effects)
  • Gastrointestinal Microbiome (drug effects)
  • Hypoglycemic Agents (pharmacology)
  • Liver (metabolism)
  • Oxidative Stress (drug effects)
  • Polysaccharides (pharmacology)
  • RNA, Ribosomal, 16S
  • Rats
  • Sargassum (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: